Pierluigi Navarra Selected Research

Glucose (Dextrose)

8/2013	The role of small intestinal bacterial overgrowth in Parkinson's disease.
11/2009	Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierluigi Navarra Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 03/2002
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2002
7	Pain (Aches) 11/2018 - 03/2009
6	Glioma (Gliomas) 11/2020 - 10/2002
6	Migraine Disorders (Migraine) 10/2020 - 08/2009
6	Infections 07/2020 - 01/2012
5	Melanoma (Melanoma, Malignant) 01/2022 - 04/2008
4	Hypersensitivity (Allergy) 05/2016 - 04/2011
3	Critical Illness (Critically Ill) 10/2020 - 01/2015
3	Multiple Sclerosis 05/2019 - 01/2002
3	Inflammation (Inflammations) 01/2017 - 06/2008
3	Hypoxia (Hypoxemia) 11/2009 - 12/2004
2	Macular Degeneration (Age-Related Maculopathy) 11/2020 - 01/2020
2	Chronic Pain 07/2020 - 01/2015
2	Brain Neoplasms (Brain Tumor) 03/2020 - 03/2004
2	Neuroblastoma 10/2019 - 09/2015
2	Alzheimer Disease (Alzheimer's Disease) 05/2019 - 10/2006
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2012
2	Disease Progression 03/2013 - 02/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 08/2009 - 11/2004
2	Endometrial Neoplasms (Endometrial Cancer) 06/2009 - 02/2006
2	Breast Neoplasms (Breast Cancer) 01/2007 - 07/2003
2	Depressive Disorder (Melancholia) 10/2006 - 02/2005
2	Fever (Fevers) 06/2006 - 03/2005
2	Colonic Neoplasms (Colon Cancer) 01/2005 - 12/2004
2	Adenocarcinoma 07/2003 - 03/2002
1	Secondary Hyperparathyroidism 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Vitamin D Deficiency 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 10/2019
1	Parkinson Disease (Parkinson's Disease) 05/2019
1	AIDS Dementia Complex 05/2019

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2021 - 10/2002
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2004
6	Monoclonal AntibodiesIBA 01/2022 - 01/2012
5	Calcitonin Gene-Related PeptideIBA 10/2020 - 08/2009
5	Peptides (Polypeptides)IBA 01/2019 - 11/2004
5	Corticotropin-Releasing HormoneIBA 09/2015 - 02/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2004
4	abacavir (Ziagen)FDA Link 05/2016 - 04/2011
4	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 09/2015 - 03/2002
4	Temozolomide (Temodar)FDA LinkGeneric 06/2008 - 10/2002
4	ProstaglandinsIBA 06/2006 - 10/2003
3	IpilimumabIBA 01/2022 - 01/2012
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 03/2013
3	HLA-B57 antigenIBA 05/2016 - 04/2011
3	Messenger RNA (mRNA)IBA 09/2015 - 06/2006
3	Phosphotransferases (Kinase)IBA 01/2015 - 03/2013
3	Estrogens (Estrogen)FDA Link 08/2014 - 07/2003
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2009 - 10/2003
3	Valproic Acid (Depakote)FDA LinkGeneric 06/2008 - 07/2003
3	Antineoplastic Agents (Antineoplastics)IBA 06/2008 - 03/2004
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	NivolumabIBA 01/2022 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2022
2	Retinaldehyde (Retinal)IBA 11/2020 - 05/2019
2	Conditioned Culture MediaIBA 11/2020 - 07/2014
2	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2020 - 01/2017
2	Tigecycline (Tygacil)FDA Link 10/2020 - 07/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	LigandsIBA 01/2020 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2019 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 10/2019 - 08/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019 - 03/2005
2	Interleukin-10 (Interleukin 10)IBA 09/2017 - 07/2014
2	Maraviroc FDA Link 09/2017 - 01/2012
2	Chemokine ReceptorsIBA 09/2017 - 01/2012
2	TOR Serine-Threonine KinasesIBA 01/2015 - 07/2014
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014 - 03/2009
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 11/2009
2	Atazanavir Sulfate (Reyataz)FDA Link 06/2013 - 04/2011
2	flupirtineIBA 01/2012 - 01/2011
2	Analgesics (Analgesic Drugs)IBA 01/2012 - 03/2009
2	Formaldehyde (Formol)FDA Link 01/2011 - 03/2009
2	Antidepressive Agents (Antidepressants)IBA 10/2006 - 02/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2006 - 02/2005
2	Endothelin-1 (Endothelin 1)IBA 06/2006 - 03/2005
2	Celecoxib (Celebrex)FDA Link 03/2005 - 10/2003
2	Prostaglandins EIBA 01/2005 - 12/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2004 - 10/2003
1	hydroxide ionIBA 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Calcifediol (Calcidiol)FDA Link 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	Protein Disulfide-IsomerasesIBA 11/2020
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 10/2020
1	erenumabIBA 10/2020
1	AMPA Receptors (AMPA Receptor)IBA 07/2020
1	Purinergic Receptors (Receptors, Purine)IBA 07/2020
1	Adenosine Triphosphate (ATP)IBA 07/2020
1	DNA (Deoxyribonucleic Acid)IBA 03/2020
1	Ranibizumab (Lucentis)FDA Link 01/2020
1	Designed Ankyrin Repeat ProteinsIBA 01/2020
1	MTOR InhibitorsIBA 10/2019

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2004
3	Drug Therapy (Chemotherapy) 01/2012 - 03/2004
1	Immunotherapy 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020
1	Intravitreal Injections 01/2020